Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Syndecan-1 Promotes Alveolar Type 2 Epithelial Cell Senescence during Lung Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
Syndecan-1 Promotes Alveolar Type 2 Epithelial Cell Senescence during Lung Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
Rebalancing Inflammation in Arthritis: PEPITEM as a Restorer of Immune Regulation.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 26, 2025
TH17 cells converted into exTH17 cells sustain rheumatoid-like IL-17-independent inflammatory arthritis.
Journal: Science immunology
Published: November 07, 2025
Single-Cell Analysis Reveals Peripheral Helper T Cells in Rheumatoid Arthritis-Related Interstitial Lung Disease.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 18, 2025
PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity.
Journal: Science advances
Published: September 05, 2025
Noncoding RNA TY1 reverses fibrosis in systemic sclerosis by attenuating the cGAS/STING pathway.
Journal: JCI insight
Published: July 14, 2025
Immunomodulatory Nanoparticles Enable Combination Therapies To Enhance Disease Prevention and Flare Control in Rheumatoid Arthritis.
Journal: ACS central science
Published: April 24, 2025
Disease modifying biomaterials for modulating mechanical allodynia in a preclinical model of rheumatoid arthritis.
Journal: Bioengineering & translational medicine
Published: April 16, 2025
A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic sclerosis.
Journal: The Journal of clinical investigation
Published: April 07, 2025
Modulation of the PTPRS proteoglycan switch by antibodies binding to the membrane-proximal fibronectin-type III domain.
Journal: The Journal of biological chemistry
Published: March 05, 2025
Optimization of a synoviocyte-targeted biologic for inflammatory arthritis in combination or bispecific administration with TNF inhibitors.
Journal: JCI insight
Published: March 03, 2025
Last Updated: 09/26/2026